CoChat

Nodular Lymphocyte Predominance Hodgkinʼs Disease: A Distinct Clinicopathological Entity

Mason, David Y., Banks, Peter M., Chan, John, Cleary, Michael L., Delsol, Georges, de Wolf Peeters, Chris, Falini, Brunangelo, Gatter, Kevin, Grogan, Thomas M., Harris, Nancy L., Isaacson, Peter G., Jaffe, Elaine S., Knowles, Daniel M., Miiller-Hermelink, H. Konrad, Pileri, Stefano, Ralfkiaer, Elisabeth, Stein, Harald, Warnke, Roger · 1994 · The American Journal of Surgical Pathology
Cited by 180

The DOI matches its Crossref record.

Abstract

This article reviews the evidence that the nodular form of lymphocyte predominance Hodgkin's disease ("nodular paragranuloma") should be recognised as a distinct clinico-pathological entity. The disease is characterised histologically by very large primary lymphoid follicles, containing polytypic small B lymphocytes and extensive meshworks of follicular dendritic cells. The "L and H" or "popcorn" cells scattered within the nodules show clear differences from classical Reed-Sternberg cells, both in their cytological appearance and in their marker profile, being frequently negative for CD15 and for the EBV genome, but often positive for B cell antigens, CD45 (leucocyte common antigen), CDw75 (LN1), epithelial membrane antigen (EMA) and J chain. These findings suggest that L and H cells may be Ig-synthesising monoclonal B cells. Nodular lymphocyte predominance Hodgkin's disease pursues a much more indolent courses that classical Hodgkin's disease, and long term survival is common. It has other distinctive clinical features, e.g. a unimodal age distribution, a predilection to involve single lymph nodes, and a very low incidence of thymic involvement. There is a tendency for diffuse large cell non-Hodgkin's lymphoma, usually of B cell type, to develop during the course of the disease. This type of Hodgkin's disease thus has many features that distinguish it from the nodular sclerosis and mixed cellularity varieties, and it is hoped that future studies will gather more information on its clinical behavior and on the nature of the putative neoplastic cells, as well as exploring different protocols for its treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00000478-199405000-00014

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 180

Metadata

Authors
Mason, D. Y., Banks, P. M., Chan, J., Cleary, M. L., Delsol, G., de Wolf Peeters, C., Falini, B., Gatter, K., Grogan, T. M., Harris, N. L., Isaacson, P. G., Jaffe, E. S., Knowles, D. M., Miiller-Hermelink, H. K., Pileri, S., Ralfkiaer, E., Stein, H., & Warnke, R.
Venue
The American Journal of Surgical Pathology
Published
1994-05
Volume
18
Issue
5
Pages
526-530
ISSN
0147-5185 (ISSN-L)
OpenAlex
W2044802341
Cited by
180
References
0
FWCI
11.90
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nodular Lymphocyte Predominance Hodgkinʼs Disease: A Distinct Clinicopathological Entity. https://app.cochat.ai/papers/10.1097/00000478-199405000-00014
The paper
Mason, D. Y., Banks, P. M., Chan, J., Cleary, M. L., Delsol, G., de Wolf Peeters, C., Falini, B., Gatter, K., Grogan, T. M., Harris, N. L., Isaacson, P. G., Jaffe, E. S., Knowles, D. M., Miiller-Hermelink, H. K., Pileri, S., Ralfkiaer, E., Stein, H., & Warnke, R. (1994). Nodular Lymphocyte Predominance Hodgkinʼs Disease: A Distinct Clinicopathological Entity. The American Journal of Surgical Pathology. https://doi.org/10.1097/00000478-199405000-00014

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.